Solving the problem by converting to a voucher system, as suggested by the Republicans, is easily dismissed. This proposal is merely a copout that tries to eliminate the problem rather than solve it. It merely transfers cost from the public to individuals and forces them to participate in a much more expensive healthcare arena. It would be a disaster for the individuals affected and it would require an even greater fraction of our economy be devoted to healthcare.
More moderate proposals include raising the eligibility age, and some forms of means testing. Raising the eligibility age actually increases the cost of healthcare in the country and would be devastating for many who had to spend an extra year or two searching for healthcare coverage at their advanced ages. Means testing could be part of general reform package, but, by itself, it is not likely to provide the needed savings.
A number of initiatives were included in the recent healthcare reform bill that aimed at reducing costs and making healthcare more effective. The net impact of these is yet to be known, but it is interesting to note that the rate of growth of Medicare costs has diminished considerably. It is as if the medical community has finally realized that something must be done and it has begun to act on its own before being required to. The encouragement to move to Accountable Care Organizations may not follow the government-encouraged path, but the efficiencies of integration into larger medical practice units is so obvious that it is happening already.
Starr reviews a number of proposals that have received considerable discussion such as negotiating drug prices and raising revenue by including a modest deductible or co-pay from Medicare participants. There is also the rise in Medicare tax that supports Part A that is programmed to occur.
Starr’s greatest contribution to the subject is to point out a number of obscure, but expensive, aspects of Medicare’s implementation. Consider the funding of hospital construction.
And then there is Medicare’s support for graduate medical education.
Medicare has congressionally imposed restrictions on what it can and cannot do in terms of determining which procedures and medications are reimbursable. This stymies attempts at cost effectiveness, but Starr suggests some modifications in reimbursement that he refers to as "reference pricing."
"The concept of "reference pricing" has wider relevance beyond pharmaceuticals: If one medical procedure is no more effective than another for a particular condition but the second is less expensive, Medicare should pay providers only the lesser amount. Reference pricing should receive a boost from one of the major initiatives in health-care reform—research on the comparative effectiveness of different treatments, which ought to begin providing better data on what works at what cost and what doesn’t work at all."
Starr also suggests that Medicare overpays specialists at the expense of primary care physicians, providing skewed incentives toward these two physician categories.
Medicare also has the issue of regional variance in cost of treatment. A city in one location could be charging much more per Medicare participant than a similar city a hundred miles away. Often there is no other explanation for this than different medical treatment habits or fraud. The more expensive location does not provide better care.
Surprisingly, Starr ignores fraud as an expense that can be reduced. The FBI estimates that 3-10% of healthcare costs are fraudulent. Medicare is probably a major target. If 5% of its costs could be eliminated by reducing fraud, that would add up to about $250B over a decade.
In sum, these proposals are capable of generating enormous savings over time. They are changes that protect the basic healthcare that seniors are now provided, and should be acceptable to both liberals and conservatives. Let us not make hasty decisions until we pursue these avenues.
No comments:
Post a Comment